Literature DB >> 33769361

Protective role of natural killer cells in neuropathic pain conditions.

Josephine Lassen1, Klarissa Hanja Stürner, Janne Gierthmühlen, Justina Dargvainiene, Dorthe Kixmüller, Frank Leypoldt, Ralf Baron, Philipp Hüllemann.   

Abstract

ABSTRACT: During the past few years, the research of chronic neuropathic pain has focused on neuroinflammation within the central nervous system and its impact on pain chronicity. As part of the ERA-Net NEURON consortium, we aimed to identify immune cell patterns in the cerebrospinal fluid (CSF) of patients with herpes zoster neuralgia and patients with polyneuropathy (PNP), which may contribute to pain chronicity in these neuropathic pain conditions. Cerebrospinal fluid of 41 patients (10 herpes zoster and 31 PNP) was analyzed by flow cytometry identifying lymphocyte subsets: CD4+ (T-helper cells), CD8+ (cytotoxic T cells), CD19+ (B cells), and CD56+ (natural killer [NK]) cells. At baseline and at follow-up, the somatosensory phenotype was assessed with quantitative sensory testing. In addition, the patients answered epidemiological questionnaires and the PainDETECT questionnaire. Immune cell profiles and somatosensory profiles, as well as painDETECT questionnaire scores, were analyzed and correlated to determine specific immune cell patterns, which contribute to chronic pain. We found a negative correlation (P = 0.004, r = -0.596) between the frequency of NK cells and mechanical pain sensitivity (MPS), one of the most relevant quantitative sensory testing markers for central sensitization; a high frequency of NK cells correlated with low MPS. The analysis of the individual follow-up showed a worsening of the pain condition if NK-cell frequency was low. Low NK-cell frequency is associated with signs of central sensitization (MPS), whereas high NK-cell frequency might prevent central sensitization. Therefore, NK cells seem to play a protective role within the neuroinflammatory cascade and may be used as a marker for pain chronicity.
Copyright © 2021 International Association for the Study of Pain.

Entities:  

Year:  2021        PMID: 33769361     DOI: 10.1097/j.pain.0000000000002274

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  3 in total

1.  Hepatocyte growth factor, colony-stimulating factor 1, CD40, and 11 other inflammation-related proteins are associated with pain in diabetic neuropathy: exploration and replication serum data from the Pain in Neuropathy Study.

Authors:  Emmanuel Bäckryd; Andreas Themistocleous; Anders Larsson; Torsten Gordh; Andrew S C Rice; Solomon Tesfaye; David L Bennett; Björn Gerdle
Journal:  Pain       Date:  2022-05-01       Impact factor: 6.961

2.  Regulatory T-cells inhibit microglia-induced pain hypersensitivity in female mice.

Authors:  Julia A Kuhn; Ilia D Vainchtein; Joao Braz; Katherine Hamel; Mollie Bernstein; Veronica Craik; Madelene W Dahlgren; Jorge Ortiz-Carpena; Ari B Molofsky; Anna V Molofsky; Allan I Basbaum
Journal:  Elife       Date:  2021-10-15       Impact factor: 8.140

Review 3.  Emerging roles of circular RNAs in neuropathic pain.

Authors:  Derong Xu; Xuexiao Ma; Chong Sun; Jialuo Han; Chuanli Zhou; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2021-10-08       Impact factor: 6.831

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.